We performed an experiment to study the role of Egr1 and Src on 15(S)-hydroxyeicosatetraenoic acid [15(S)-HETE]–induced human dermal microvascular endothelial cell tube formation. The data were split between Figure 1D (page 2107) and Figure 2D (page 2108) for better presentation, and an overlapping image for Ad-GFP + 15(S)-HETE treatment was inserted inadvertently in both Figure 1D and Figure 2D. Since it is one of several images of the Ad-GFP + 15(S)-HETE treatment group that were used for comparing the effects of dn-Egr1 + 15(S)-HETE and dn-Src + 15(S)-HETE treatments from the same experiment and the bar graphs in the figures show quantitative data of several replicates with statistical analysis, it does not affect the results or the conclusions of the study.
. 2021 Feb 25;137(8):1131. doi: 10.1182/blood.2021010742
Kundumani-Sridharan V, Niu J, Wang D, et al. 15(S)-hydroxyeicosatetraenoic acid–induced angiogenesis requires Src-mediated Egr-1–dependent rapid induction of FGF-2 expression. Blood. 2010;115(10):2105-2116.
© 2021 by The American Society of Hematology
This article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC8555386 PMID: 33630057
This corrects the article "15(S)-hydroxyeicosatetraenoic acid–induced angiogenesis requires Src-mediated Egr-1–dependent rapid induction of FGF-2 expression" in volume 115 on page 2105.